EX-99.2 2 drr0420_ex99-2.htm EXHIBIT 99.2

 

Exhibit 99.2

 

Dr. Reddy’s Laboratories Ltd.

8-2-337, Road No. 3, Banjara Hills,

Hyderabad - 500 034, Telangana,
India.

CIN : L85195TG1984PLC004507    

 

Tel      : +91 40 4900 2900

Fax     : +91 40 4900 2999

Email : mail@drreddys.com

www.drreddys.com

 

August 6, 2022

 

National Stock Exchange of India Ltd. (Scrip Code: DRREDDY-EQ)

BSE Limited (Scrip Code: 500124)

 

Dear Sirs,

 

Sub: Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Schedule of Analyst / Institutional Investor Meetings

 

This is to inform you that the Company’s management will be participating in the following investor conferences for group and one-on-one meetings:

 

Date Conferences Venue
10th August, 2022 Emkay Confluence – Ideas for a $ 5trn Economy Mumbai, India
10th August, 2022 Pharma Conference – Path to The Next Normal Mumbai, India

 

Please note that the schedule of the aforesaid meetings is subject to change due to any exigencies on the part of investors / Company.

 

This is for your information.

 

Thanking you.

 

Yours faithfully,

For Dr. Reddy’s Laboratories Limited

 

/s/ K Randhir Singh  
K Randhir Singh  

Company Secretary & Compliance Officer

 

CC:- New York Stock Exchange Inc.(Stock Code :RDY)

         NSE IFSC Ltd